OptimizeRx Corp — Director's Dealing 2021

Sep 15, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OptimizeRx Corp (OPRX)
CIK: 0001448431
Period of Report: 2021-09-13

Reporting Person: FEBBO WILLIAM J (Director, CHIEF EXECUTIVE OFFICER)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-09-13	Common Stock	G	8600	—	Disposed	536041	Direct

Footnotes

F1: Shares represent a charitable gift/donation to the National Philanthropic Trust/William and Vanessa Febbo. The Reporting Person is not a Trustee and has no pecuniary interest or investment discretion.

F2: Price is not applicable to acquisitions or dispositions resulting from bona fide gifts.